BDPT (BioAdaptives) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 08, 2026)


What is BioAdaptives 5-Year Yield-on-Cost %?

BioAdaptives BDPT 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. The stock has 5 warning signs investors should review. Among 1,171 Consumer Packaged Goods companies, BioAdaptives ranks worse than 85397.01% on this metric.

BioAdaptives's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for BioAdaptives's 5-Year Yield-on-Cost % or its related term are showing as below:



BDPT's 5-Year Yield-on-Cost % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.41
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

BioAdaptives  (OTCPK:BDPT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

BioAdaptives 5-Year Yield-on-Cost % Related Terms

BDPT vs NBND, BSFC, MEHA: 5-Year Yield-on-Cost % Comparison

For the Packaged Foods subindustry, BioAdaptives's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioAdaptives 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where BioAdaptives's 5-Year Yield-on-Cost % falls into.


BioAdaptives 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of BioAdaptives is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
BioAdaptives (BDPT) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on BioAdaptives and its competitors. According to the industry distribution chart, BioAdaptives ranks #999999 out of 1171 companies in the Consumer Packaged Goods industry.
Is BioAdaptives' 5-Year Yield-on-Cost % too high?
BioAdaptives' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, BioAdaptives ranks #999999 out of 1171 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does BioAdaptives' 5-Year Yield-on-Cost % compare to NBND and BSFC?
According to the Consumer Packaged Goods industry distribution chart, BioAdaptives ranks #999999 out of 1171 companies for 5-Year Yield-on-Cost %. This places BioAdaptives in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.41, based on 1,171 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on BioAdaptives and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioAdaptives's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioAdaptives stock overvalued right now?
BioAdaptives (BDPT) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For BioAdaptives (BDPT), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioAdaptives Business Description

Address 2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.